Pharming (PHAR) Cash from Discontinued Operations (2019 - 2025)

Pharming (PHAR) Cash from Discontinued Operations (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 7.90 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Pharming 824.47 Mn 666.19 Mn 141.47 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 54.71 Mn
Dec 31, 2025 54.71 Mn
Dec 31, 2024 -1.80 Mn
Dec 31, 2024 -1.80 Mn
Sep 30, 2024 9.74 Mn
Sep 30, 2024 9.74 Mn
Dec 31, 2023 -17.30 Mn
Dec 31, 2023 -17.30 Mn
Sep 30, 2023 3.53 Mn
Sep 30, 2023 3.53 Mn
Jun 30, 2023 -32.41 Mn
Jun 30, 2023 -32.41 Mn
Dec 31, 2022 609,000.00
Dec 31, 2022 609,000.00
Sep 30, 2022 12.62 Mn
Sep 30, 2022 12.62 Mn
Dec 31, 2021 7.06 Mn
Dec 31, 2021 7.06 Mn
Sep 30, 2021 5.51 Mn
Sep 30, 2021 5.51 Mn